Trial
NCT00153842
A Study of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules in Patients With Advanced Lung Cancer
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Dartmouth-Hitchcock Medical Center
Collaborators
Bristol-Myers Squibb; Ligand Pharmaceuticals
Condition
Carcinoma, Non-small-cell Lung
Intervention
Bexarotene (targretin)
Why stopped
other trials show no survival benefit of bexarotene with platinum-based chemo
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-03-06